Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc.AVAH · Entity 4246 | Director | February 14, 2026 | February 17, 2026 |
| Elicio Therapeutics, Inc.ANGN · Entity 299 | Director | June 09, 2022 | June 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aveanna Healthcare Holdings, Inc.
Report date February 14, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 502,522 |
Reported balance
After 2026-02-14 transaction · row 1
1 source rowRow 1 · 2026-02-14 · Grant · Acquired 18,916 · Balance 502,522 F1: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting.
Elicio Therapeutics, Inc.
Report date June 09, 2022 · Filed June 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.73 · Expires 2032-06-09 | Direct | 15,000 |
Reported balance
After 2022-06-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-09 · Grant · Acquired 15,000 · Balance 15,000 F1: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WILLIS TOWERS WATSON PLC
Report date June 08, 2022 · Filed June 10, 2022
Section 16 reporting ended · disclosed 2022-06-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, nominal value $0.000304635 per shareSEC Table I · non-derivative | Direct | 21,378 |
Reported balance
After 2022-06-08 transaction · row 1
1 source rowRow 1 · 2022-06-08 · Tax withholding · Disposed 128 · Balance 21,378 F1: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 265 restricted share units granted on January 3, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 265 restricted share units granted on January 3, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 14, 2026 Filed Feb 17, 2026 17:30 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 18,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-055168 · ownership.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 502,522 F1 · shares: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:48 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 28,261 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032990 · ownership.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,606 F1 · price: Grant of stock-settled restricted stock unit, subject to one-year cliff vesting. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 20:56 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantCommon Stock, par value $0.01 per share | 53,942 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-019667 · ownership.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 455,345 F1 · price: Grant of stock-settled restricted stock unit, subject to one year cliff vesting. Read SEC document |
| February 14, 2024 Filed Feb 20, 2024 21:44 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionRestricted Stock Units · Derivative | 103,175 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-017527 · ownership.xml · derivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 103,175 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: On February 14, 2023, the reporting person was granted 103,175 RSUs, which vested on February 14, 2024. F2 · derivative.expiration_date: On February 14, 2023, the reporting person was granted 103,175 RSUs, which vested on February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 20, 2024 21:44 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionCommon Stock | 103,175 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-017527 · ownership.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. Read SEC document |
| August 15, 2023 Filed Aug 24, 2023 18:28 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionRestricted Stock Units · Derivative | 61,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-044445 · ownership.xml · derivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 61,611 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: On August 15, 2022, the reporting person was granted 61,611 restricted stock units, which vested on August 15, 2023. F2 · derivative.expiration_date: On August 15, 2022, the reporting person was granted 61,611 restricted stock units, which vested on August 15, 2023. Read SEC document |
| August 15, 2023 Filed Aug 24, 2023 18:28 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionCommon Stock | 61,611 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-044445 · ownership.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share, of Aveanna Healthcare Holdings Inc. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:50 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | PurchaseCommon Stock, par value $0.01 per share | 200 | $1.23 | $246.00 |
DisclosureSEC source: 0000899243-23-015025 · doc4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,617 Read SEC document |
| June 01, 2023 Filed Jun 1, 2023 20:55 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | PurchaseCommon Stock, par value $0.01 per share | 3,200 | $1.18 | $3,776.00 |
DisclosureSEC source: 0000899243-23-014279 · doc4.xml · nonDerivative · entry 3 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,417 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.145 to $1.20, inclusive. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 20:55 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | PurchaseCommon Stock, par value $0.01 per share | 11,850 | $1.15 | $13,615.65 |
DisclosureSEC source: 0000899243-23-014279 · doc4.xml · nonDerivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 233,217 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.10 to $1.20, inclusive. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 20:55 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | PurchaseCommon Stock, par value $0.01 per share | 1,758 | $1.14 | $2,007.64 |
DisclosureSEC source: 0000899243-23-014279 · doc4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,367 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.12 to $1.15, inclusive. The reporting person undertakes to provide to Aveanna Healthcare Holdings Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 20:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantRestricted Stock Units · Derivative | 103,175 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005310 · doc4.xml · derivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,175 Underlying: Common Stock, par value $0.01 per share · 103,175 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. F2 · derivative.expiration_date: The RSUs vest on February 14, 2024. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 18:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantRestricted Stock Units · Derivative | 61,611 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-029050 · doc4.xml · derivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,611 Underlying: Common Stock, par value $0.01 per share · 61,611 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. F2 · derivative.expiration_date: The RSUs vest on August 15, 2023. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionRestricted Stock Units · Derivative | 10,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-025153 · doc4.xml · derivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.01 per share · 10,509 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. F2 · derivative.exercise_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022. F2 · derivative.expiration_date: On June 30, 2021, the reporting person was granted 10,509 restricted stock units, which vested on June 30, 2022. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 21:00 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | Exercise / conversionCommon Stock | 10,509 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-025153 · doc4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit converts into one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 17:27 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000053 · wf-form4_165515561728971.xml · derivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:01 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 128 | $209.84 | $26,859.52 |
DisclosureSEC source: 0001127602-22-017221 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,378 F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 265 restricted share units granted on January 3, 2022. Read SEC document |
| May 11, 2022 Filed May 13, 2022 20:04 UTC | WILLIS TOWERS WATSON PLC WTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 791 | $206.35 | $163,222.85 |
DisclosureSEC source: 0001127602-22-014390 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,506 F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 1,646 restricted share units granted on May 11, 2021. F2 · balance_after: Includes 265 time-based restricted share units subject to the satisfaction of vesting requirements. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:09 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000931 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,297 F1 · shares: Comprised of 265 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the date of the Issuer's 2022 Annual General Meeting of Shareholders. F2 · balance_after: Includes 1,911 time-based RSUs subject to the satisfaction of vesting requirements. Read SEC document |
| June 30, 2021 Filed Jul 6, 2021 16:47 UTC | Aveanna Healthcare Holdings, Inc. AVAH · Entity 4246 | GrantRestricted Stock Units · Derivative | 10,509 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-027537 · doc4.xml · derivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,509 Underlying: Common Stock, par value $0.01 per share · 10,509 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") provides for the right to receive one share of common stock, $0.01 par value per share ("common stock"), of Aveanna Healthcare Holdings Inc. . F2 · derivative.exercise_date: The RSUs vest on June 30, 2022. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. F2 · derivative.expiration_date: The RSUs vest on June 30, 2022. Common stock in respect of vested RSUs will be delivered to the reporting person as soon as practicable following the vesting date, and, in any event, within 60 days following such date. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:04 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 1,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016540 · form4.xml · nonDerivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,032 F2 · shares: Comprised of 1,646 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on the earlier of May 11, 2022 and the Issuer's 2022 Annual General Meeting of Shareholders, and are subject to pro-rata vesting based on the period served through the effective time of the business combination between the Issuer and Aon plc. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:04 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 1,049 | $264.25 | $277,198.25 |
DisclosureSEC source: 0001127602-21-016540 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,386 F1 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 2,184 restricted share units granted on June 10, 2020. Read SEC document |
| March 08, 2021 Filed Mar 10, 2021 16:11 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $15.01 | $0.00 |
DisclosureSEC source: 0001567619-21-005972 · doc1.xml · derivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-03-07 F1 · derivative.exercise_date: To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | OtherWarrant to Purchase Common Stock · Derivative | 367,590 | $0.00 Strike: $6.43 | $0.00 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · derivative · entry 8 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 367,590 shares Expires 2028-07-05 F2 · derivative.exercise_date: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's IPO price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's IPO, the Issuer withheld 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $16.00 | $579,901.31 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · derivative · entry 7 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock. F5 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of August 21, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $16.00 | $216,832.88 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · derivative · entry 6 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 216,832.88 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The convertible promissory note converted immediately prior to the consummation of the IPO into Common Stock. F4 · derivative.expiration_date: The convertible promissory note ("Convertible Note") had a maturity date of May 28, 2021 and the principal amount of the Convertible Note converted upon the closing of the IPO into Common Shares at a conversion price equal to $18.00 per Common Share. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | SaleCommon Stock | 246,720 | $16.00 | $3,947,520.00 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 5 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576,397 F2 · balance_after: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's IPO price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's IPO, the Issuer withheld 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | OtherCommon Stock | 367,590 | $6.43 | $2,363,603.70 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 4 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,117 F2 · balance_after: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $16.00 a share, which represents the Issuer's IPO price. In connection with the automatic net exercise of the warrant immediately prior to the closing of the Issuer's IPO, the Issuer withheld 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionCommon Stock | 50,122 | $11.57 | $579,911.54 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 3 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed Feb 11, 2021 19:22 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | ConversionCommon Stock | 18,741 | $11.57 | $216,833.37 |
DisclosureSEC source: 0001567619-21-003189 · doc1.xml · nonDerivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 405,405 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2021 Filed May 27, 2022 16:19 UTC Amendment | Elicio Therapeutics, Inc. ANGN · Entity 299 | OtherWarrant to Purchase Common Stock · Derivative | 614,310 | $0.00 Strike: $6.43 | $0.00 |
DisclosureSEC source: 0001601485-22-000044 · wf-form4a_165368270982659.xml · derivative · entry 3 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 614,310 shares Expires 2028-07-05 F1 · derivative.exercise_date: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person. Read SEC document |
| February 09, 2021 Filed May 27, 2022 16:19 UTC Amendment | Elicio Therapeutics, Inc. ANGN · Entity 299 | SaleCommon Stock | 246,720 | $16.00 | $3,947,520.00 |
DisclosureSEC source: 0001601485-22-000044 · wf-form4a_165368270982659.xml · nonDerivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,117 F1 · kind: On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person. Read SEC document |
| February 09, 2021 Filed May 27, 2022 16:19 UTC Amendment | Elicio Therapeutics, Inc. ANGN · Entity 299 | OtherCommon Stock | 614,310 | $6.43 | $3,950,013.30 |
DisclosureSEC source: 0001601485-22-000044 · wf-form4a_165368270982659.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,069,837 Read SEC document |
| June 10, 2020 Filed Jun 11, 2020 21:06 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019442 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,435 F1 · shares: Comprised of 2,184 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on June 10, 2021. Read SEC document |
| May 20, 2019 Filed May 22, 2019 20:02 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 1,757 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-019421 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,251 F1 · shares: Comprised of 1,757 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on May 20, 2020. F2 · balance_after: Includes an aggregate of 2,770 RSUs subject to vesting requirements. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 20:08 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | Tax withholdingOrdinary Shares, nominal value $0.000304635 per share | 476 | $147.95 | $70,424.20 |
DisclosureSEC source: 0001127602-18-025462 · form4.xml · nonDerivative · entry 2 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,494 F2 · shares: Withholding of shares by Issuer incident to the tax payment related to the vesting and settlement of 991 RSUs granted on August 14, 2017. F3 · balance_after: Includes 1,013 RSUs noted in footnote (1). Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 20:08 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 1,013 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-025462 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,970 F1 · shares: Comprised of 1,013 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on August 13, 2019. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 20:07 UTC | WILLIS TOWERS WATSON PLC WLTW · Entity 3139 | GrantOrdinary Shares, nominal value $0.000304635 per share | 991 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-025762 · form4.xml · nonDerivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,957 F1 · shares: Comprised of 991 restricted share units ("RSUs"), which represent the right to receive ordinary shares, par value $0.000304635 per share, of the Issuer. The RSUs shall vest in full on August 14, 2018. F2 · balance_after: Includes 991 RSUs noted in footnote (1) and gives effect to vests of RSUs granted in August 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.